Cargando…
Phosphorylation of SMAD3 in immune cells predicts survival of patients with early stage non-small cell lung cancer
BACKGROUND: The interplay of immune and cancer cells takes place in the tumor microenvironment where multiple signals are exchanged. The transforming growth factor beta (TGFB) pathway is known to be dysregulated in lung cancer and can impede an effective immune response. However, the exact mechanism...
Autores principales: | Marwitz, Sebastian, Ballesteros-Merino, Carmen, Jensen, Shawn M, Reck, Martin, Kugler, Christian, Perner, Sven, Drömann, Daniel, Goldmann, Torsten, Fox, Bernard A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887360/ https://www.ncbi.nlm.nih.gov/pubmed/33589523 http://dx.doi.org/10.1136/jitc-2020-001469 |
Ejemplares similares
-
Human alveolar epithelial cells type II are capable of TGFβ-dependent epithelial-mesenchymal-transition and collagen-synthesis
por: Goldmann, Torsten, et al.
Publicado: (2018) -
Epigenetic modifications of the immune-checkpoint genes CTLA4 and PDCD1 in non-small cell lung cancer results in increased expression
por: Marwitz, Sebastian, et al.
Publicado: (2017) -
Fountain of youth for squamous cell carcinomas? On the epigenetic age of non‐small cell lung cancer and corresponding tumor‐free lung tissues
por: Marwitz, Sebastian, et al.
Publicado: (2018) -
Epigenetic modifications of the VGF gene in human non-small cell lung cancer tissues pave the way towards enhanced expression
por: Marwitz, Sebastian, et al.
Publicado: (2017) -
Live and let die: epigenetic modifications of Survivin and Regucalcin in non-small cell lung cancer tissues contribute to malignancy
por: Nitschkowski, Dörte, et al.
Publicado: (2019)